20/20 Biolabs, Inc. (AIDX)
0.3627
-0.01
(-3.28%)
USD |
NASDAQ |
Oct 12, 13:55
20/20 Biolabs Net Income (Quarterly) : -1.506M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.506M |
| March 31, 2026 | -2.175M |
| December 31, 2025 | -1.308M |
| September 30, 2025 | -0.8255M |
| March 31, 2025 | -0.7646M |
| Date | Value |
|---|---|
| December 31, 2024 | -1.249M |
| September 30, 2024 | -1.874M |
| June 30, 2023 | -1.717M |
| March 31, 2023 | -1.995M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Sanara MedTech, Inc. | -0.4111M |
| Intelligent Bio Solutions, Inc. | -3.917M |
| Anteris Technologies Global Corp. | -28.78M |
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.7306M |
| Total Expenses (Quarterly) | 2.237M |
| EPS Diluted (Quarterly) | -0.2247 |
| Enterprise Value | 2.159M |
| Gross Profit Margin (Quarterly) | 41.71% |
| Profit Margin (Quarterly) | -206.2% |
| Earnings Yield | -199.3% |